Doxorubicin-associated Cardiomyopathy: New Approaches to Pharmacological Correction Using 3-(2,2,2-trimethylhydrazinium) Propionate Derivatives
Introduction: The search for new compounds with cardioprotective activity amongst the 3-(2,2,2-trimethylhydrazinium) propionate derivatives looks promising. Research objectives: to study cardioprotective effects of the 3-(2,2,2-trimethylhydrazinium) propionate derivatives. Methods: The cardioprotect...
Saved in:
Main Author: | Lyudmila M. Danilenko (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOLOGICAL CORRECTION OF L-NAME-INDUCED OXIDE DEFICIENCY WITH DERIVATIVES OF 3-(2,2,2- TRIMETHYLHYDRAZINIUM) PROPIONATE
by: Sophiya Ya. Skachilova, et al.
Published: (2016) -
PHARMACOLOGICAL PROTECTION OF THE ISCHEMIC MYOCARDIUM BY DERIVATIVES OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE AND EVALUATION OF THEIR ANTIOXIDANT ACTIVITY
by: Sophiya Ya. Skachilova, et al.
Published: (2015) -
Experimental study of new derivatives of 3-hydroxypyridine as pharmacological agents for the correction of ischemic brain injury after intracerebral hemorrhage
by: Olesya V. Shcheblykina, et al.
Published: (2022) -
Pharmacological screening of substances with cardioprotective effect in the group of 3-oxypyridine derivatives
by: Lyudmila M. Danilenko, et al.
Published: (2018) -
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals
by: Matthias Kuntzsch, et al.
Published: (2014)